Researchers develop novel targeted therapy for triple-negative breast cancer

[News]

Researchers from Hong Kong Baptist University (HKBU), in collaboration with Cornell University, have developed a novel targeted therapy for triple-negative breast cancer (TNBC) that uses a specially-designed nano-carrier to deliver the Chinese medicine compound gambogic acid (GA).

More... (https://www.news-medical.net/news/20210512/Researchers-develop-novel-targeted-therapy-for-triple-negative-breast-cancer.aspx)